Is approving esketamine as an antidepressant for treatment resistant depression associated with recreational use and risk perception of ketamine? Results from a longitudinal and cross-sectional survey in nightlife attendees
- Resource Type
- Article
- Source
- In
International Journal of Drug Policy April 2022 102 - Subject
- Language
- ISSN
- 0955-3959